Health economics and cost-effectiveness analysis
10 European H2020 organizations list this as part of their work — 1 as their primary capability.
Most active in this area
- KLINIKUM DER UNIVERSITAET ZU KOELN
German university hospital combining neuroscience, cancer biology, and clinical trials with growing strength in health economics and cost-effectiveness evaluation.
“Recent projects FURTHER, iLIVE, and BETTER-B all include cost-effectiveness evaluation components, with 'cost-effectiveness' appearing as the most frequent recent-period keyword.”
DE41 projects - NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
UK's national authority on health technology assessment, contributing HTA, health economics, and data standards expertise to European health research consortia.
“Contributed health economics expertise in ROADMAP (Alzheimer's), VALUE-Dx (antimicrobial resistance), CoroPrevention, and IMPACT HTA.”
PrimaryUK13 projects - PARC SANITARI SANT JOAN DE DEU
Barcelona-area healthcare institution specializing in mental health research, epidemiological cohort studies, and health intervention implementation across Europe and Latin America.
“Both EMPOWER and IMA-cRCT explicitly include cost-effectiveness evaluation and economic modelling as core methodologies.”
ES9 projects - FUNDACIO INSTITUT UNIVERSITARI PERA LA RECERCA A L'ATENCIO PRIMARIA DE SALUT JORDI GOL I GURINA
Barcelona-based primary care research institute providing real-world patient evidence, disease screening, and health economics expertise to European health consortia.
“ROADMAP explicitly includes health economics of Alzheimer's care; LiverScreen involves cost-effectiveness analysis of screening methodologies.”
ES5 projects - VARSINAIS-SUOMEN HYVINVOINTIALUE
Finnish regional health authority providing clinical validation, patient data, and hospital infrastructure for AI-driven diagnostics and cancer research.
“FURTHER includes health care economics and cost-effectiveness evaluation of focused ultrasound vs radiotherapy.”
FI4 projects - CENTRE HOSPITALIER UNIVERSITAIRE DEBESANCON
French university hospital contributing clinical trial sites, patient cohorts, and health economics expertise across cardiovascular, neurological, and psychiatric research.
“SECURE explicitly addressed cost-effectiveness and medication adherence; RESSTORE included health economics modelling.”
FR4 projects - MEDIOLANUM CARDIO RESEARCH SRL
Milan-based clinical research firm specializing in neurodegenerative disease care and cardiovascular in-silico modelling for EU health consortia.
“RECAGE explicitly listed cost-effectiveness as a keyword; PD_Pal's palliative care focus implies health resource evaluation.”
IT3 projects - HELIOS HEALTH INSTITUTE GMBH
Berlin clinical research institute specialising in cardiovascular risk prediction, integrated care for multimorbid patients, and hospital-embedded clinical trial implementation.
“Cost-effectiveness is listed as a key theme in EHRA-PATHS, suggesting the institute contributes economic evaluation capabilities alongside clinical research.”
SMEDE2 projects - UNIVERSITETI I MJEKESISE TIRANE
Albanian medical university specialising in community health screening, chronic disease self-management, and digital health implementation in primary care settings.
“EUSCREEN explicitly included cost-optimisation and comparative cost-effectiveness analysis, indicating UMT's engagement with health system efficiency research.”
AL2 projects - STICHTING ISALA KLINIEKEN
Dutch teaching hospital providing clinical trial capacity in cardiac rehabilitation, interventional oncology, and MR-guided focused ultrasound.
“FURTHER explicitly targets health care economics and cost-effectiveness as key outputs, reflecting the hospital's capacity to pair clinical trial work with economic evaluation.”
NL2 projects